Click for best price
Cholera Vaccines Market Size, Share 2024
| Market size in 2023 |
US$ 78 million
|
Forecast Market size by 2030 |
US$ 149.4 million
|
| Growth Rate |
CAGR of 9.5% |
Number of Pages |
108 Pages |
The global Cholera Vaccines market was valued at US$ 78 million in 2023 and is projected to reach US$ 149.4 million by 2030, at a CAGR of 9.5% during the forecast period.
The USA market for Global Cholera Vaccines market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Cholera Vaccines market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Cholera Vaccines market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Cholera Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cholera Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cholera Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global Cholera Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cholera Vaccines market presents opportunities for various stakeholders, including Oral, Others. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cholera Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Cholera Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cholera Vaccines market.
Market Overview: The report provides a comprehensive overview of the Cholera Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Dukoral, Shanchol), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cholera Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cholera Vaccines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cholera Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cholera Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cholera Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cholera Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cholera Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cholera Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cholera Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Dukoral
- Shanchol
- Vaxchora
- Others
Market segment by Application
Global Cholera Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
- Major players covered
- Shantha Biotechnics Private Limited
- PaxVax, Inc.
- Valneva SE
- Merck and Co., Inc.
- GlaxoSmithKline plc (GSK)
- Astellas Pharma, Inc.
- Pfizer, Inc.
- Emergent BioSolutions, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Takeda Pharmaceutical Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cholera Vaccines, market overview.
Chapter 2: Global Cholera Vaccines market size in revenue.
Chapter 3: Detailed analysis of Cholera Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cholera Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cholera Vaccines Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 78 million
|
| Forecast Market size by 2030 |
US$ 149.4 million
|
| Growth Rate |
CAGR of 9.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cholera Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cholera Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cholera Vaccines Overall Market Size
2.1 Global Cholera Vaccines Market Size: 2023 VS 2030
2.2 Global Cholera Vaccines Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cholera Vaccines Players in Global Market
3.2 Top Global Cholera Vaccines Companies Ranked by Revenue
3.3 Global Cholera Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Cholera Vaccines Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cholera Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cholera Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Cholera Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Cholera Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cholera Vaccines Market Size Markets, 2023 & 2030
4.1.2 Dukoral
4.1.3 Shanchol
4.1.4 Vaxchora
4.1.5 Others
4.2 By Type - Global Cholera Vaccines Revenue & Forecasts
4.2.1 By Type - Global Cholera Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Cholera Vaccines Revenue, 2025-2030
4.2.3 By Type - Global Cholera Vaccines Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cholera Vaccines Market Size, 2023 & 2030
5.1.2 Oral
5.1.3 Others
5.2 By Application - Global Cholera Vaccines Revenue & Forecasts
5.2.1 By Application - Global Cholera Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Cholera Vaccines Revenue, 2025-2030
5.2.3 By Application - Global Cholera Vaccines Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cholera Vaccines Market Size, 2023 & 2030
6.2 By Region - Global Cholera Vaccines Revenue & Forecasts
6.2.1 By Region - Global Cholera Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Cholera Vaccines Revenue, 2025-2030
6.2.3 By Region - Global Cholera Vaccines Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cholera Vaccines Revenue, 2019-2030
6.3.2 US Cholera Vaccines Market Size, 2019-2030
6.3.3 Canada Cholera Vaccines Market Size, 2019-2030
6.3.4 Mexico Cholera Vaccines Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cholera Vaccines Revenue, 2019-2030
6.4.2 Germany Cholera Vaccines Market Size, 2019-2030
6.4.3 France Cholera Vaccines Market Size, 2019-2030
6.4.4 U.K. Cholera Vaccines Market Size, 2019-2030
6.4.5 Italy Cholera Vaccines Market Size, 2019-2030
6.4.6 Russia Cholera Vaccines Market Size, 2019-2030
6.4.7 Nordic Countries Cholera Vaccines Market Size, 2019-2030
6.4.8 Benelux Cholera Vaccines Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cholera Vaccines Revenue, 2019-2030
6.5.2 China Cholera Vaccines Market Size, 2019-2030
6.5.3 Japan Cholera Vaccines Market Size, 2019-2030
6.5.4 South Korea Cholera Vaccines Market Size, 2019-2030
6.5.5 Southeast Asia Cholera Vaccines Market Size, 2019-2030
6.5.6 India Cholera Vaccines Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cholera Vaccines Revenue, 2019-2030
6.6.2 Brazil Cholera Vaccines Market Size, 2019-2030
6.6.3 Argentina Cholera Vaccines Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cholera Vaccines Revenue, 2019-2030
6.7.2 Turkey Cholera Vaccines Market Size, 2019-2030
6.7.3 Israel Cholera Vaccines Market Size, 2019-2030
6.7.4 Saudi Arabia Cholera Vaccines Market Size, 2019-2030
6.7.5 UAE Cholera Vaccines Market Size, 2019-2030
7 Cholera Vaccines Companies Profiles
7.1 Shantha Biotechnics Private Limited
7.1.1 Shantha Biotechnics Private Limited Company Summary
7.1.2 Shantha Biotechnics Private Limited Business Overview
7.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Major Product Offerings
7.1.4 Shantha Biotechnics Private Limited Cholera Vaccines Revenue in Global Market (2019-2024)
7.1.5 Shantha Biotechnics Private Limited Key News & Latest Developments
7.2 PaxVax, Inc.
7.2.1 PaxVax, Inc. Company Summary
7.2.2 PaxVax, Inc. Business Overview
7.2.3 PaxVax, Inc. Cholera Vaccines Major Product Offerings
7.2.4 PaxVax, Inc. Cholera Vaccines Revenue in Global Market (2019-2024)
7.2.5 PaxVax, Inc. Key News & Latest Developments
7.3 Valneva SE
7.3.1 Valneva SE Company Summary
7.3.2 Valneva SE Business Overview
7.3.3 Valneva SE Cholera Vaccines Major Product Offerings
7.3.4 Valneva SE Cholera Vaccines Revenue in Global Market (2019-2024)
7.3.5 Valneva SE Key News & Latest Developments
7.4 Merck and Co., Inc.
7.4.1 Merck and Co., Inc. Company Summary
7.4.2 Merck and Co., Inc. Business Overview
7.4.3 Merck and Co., Inc. Cholera Vaccines Major Product Offerings
7.4.4 Merck and Co., Inc. Cholera Vaccines Revenue in Global Market (2019-2024)
7.4.5 Merck and Co., Inc. Key News & Latest Developments
7.5 GlaxoSmithKline plc (GSK)
7.5.1 GlaxoSmithKline plc (GSK) Company Summary
7.5.2 GlaxoSmithKline plc (GSK) Business Overview
7.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Major Product Offerings
7.5.4 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue in Global Market (2019-2024)
7.5.5 GlaxoSmithKline plc (GSK) Key News & Latest Developments
7.6 Astellas Pharma, Inc.
7.6.1 Astellas Pharma, Inc. Company Summary
7.6.2 Astellas Pharma, Inc. Business Overview
7.6.3 Astellas Pharma, Inc. Cholera Vaccines Major Product Offerings
7.6.4 Astellas Pharma, Inc. Cholera Vaccines Revenue in Global Market (2019-2024)
7.6.5 Astellas Pharma, Inc. Key News & Latest Developments
7.7 Pfizer, Inc.
7.7.1 Pfizer, Inc. Company Summary
7.7.2 Pfizer, Inc. Business Overview
7.7.3 Pfizer, Inc. Cholera Vaccines Major Product Offerings
7.7.4 Pfizer, Inc. Cholera Vaccines Revenue in Global Market (2019-2024)
7.7.5 Pfizer, Inc. Key News & Latest Developments
7.8 Emergent BioSolutions, Inc.
7.8.1 Emergent BioSolutions, Inc. Company Summary
7.8.2 Emergent BioSolutions, Inc. Business Overview
7.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Major Product Offerings
7.8.4 Emergent BioSolutions, Inc. Cholera Vaccines Revenue in Global Market (2019-2024)
7.8.5 Emergent BioSolutions, Inc. Key News & Latest Developments
7.9 Mitsubishi Tanabe Pharma Corporation
7.9.1 Mitsubishi Tanabe Pharma Corporation Company Summary
7.9.2 Mitsubishi Tanabe Pharma Corporation Business Overview
7.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Major Product Offerings
7.9.4 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue in Global Market (2019-2024)
7.9.5 Mitsubishi Tanabe Pharma Corporation Key News & Latest Developments
7.10 Takeda Pharmaceutical Co., Ltd.
7.10.1 Takeda Pharmaceutical Co., Ltd. Company Summary
7.10.2 Takeda Pharmaceutical Co., Ltd. Business Overview
7.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Major Product Offerings
7.10.4 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue in Global Market (2019-2024)
7.10.5 Takeda Pharmaceutical Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cholera Vaccines Market Opportunities & Trends in Global Market
Table 2. Cholera Vaccines Market Drivers in Global Market
Table 3. Cholera Vaccines Market Restraints in Global Market
Table 4. Key Players of Cholera Vaccines in Global Market
Table 5. Top Cholera Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cholera Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cholera Vaccines Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cholera Vaccines Product Type
Table 9. List of Global Tier 1 Cholera Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cholera Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cholera Vaccines Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cholera Vaccines Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cholera Vaccines Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cholera Vaccines Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cholera Vaccines Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cholera Vaccines Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cholera Vaccines Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cholera Vaccines Revenue, (US$, Mn), 2025-2030
Table 30. Shantha Biotechnics Private Limited Company Summary
Table 31. Shantha Biotechnics Private Limited Cholera Vaccines Product Offerings
Table 32. Shantha Biotechnics Private Limited Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 33. Shantha Biotechnics Private Limited Key News & Latest Developments
Table 34. PaxVax, Inc. Company Summary
Table 35. PaxVax, Inc. Cholera Vaccines Product Offerings
Table 36. PaxVax, Inc. Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 37. PaxVax, Inc. Key News & Latest Developments
Table 38. Valneva SE Company Summary
Table 39. Valneva SE Cholera Vaccines Product Offerings
Table 40. Valneva SE Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 41. Valneva SE Key News & Latest Developments
Table 42. Merck and Co., Inc. Company Summary
Table 43. Merck and Co., Inc. Cholera Vaccines Product Offerings
Table 44. Merck and Co., Inc. Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 45. Merck and Co., Inc. Key News & Latest Developments
Table 46. GlaxoSmithKline plc (GSK) Company Summary
Table 47. GlaxoSmithKline plc (GSK) Cholera Vaccines Product Offerings
Table 48. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 49. GlaxoSmithKline plc (GSK) Key News & Latest Developments
Table 50. Astellas Pharma, Inc. Company Summary
Table 51. Astellas Pharma, Inc. Cholera Vaccines Product Offerings
Table 52. Astellas Pharma, Inc. Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 53. Astellas Pharma, Inc. Key News & Latest Developments
Table 54. Pfizer, Inc. Company Summary
Table 55. Pfizer, Inc. Cholera Vaccines Product Offerings
Table 56. Pfizer, Inc. Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 57. Pfizer, Inc. Key News & Latest Developments
Table 58. Emergent BioSolutions, Inc. Company Summary
Table 59. Emergent BioSolutions, Inc. Cholera Vaccines Product Offerings
Table 60. Emergent BioSolutions, Inc. Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 61. Emergent BioSolutions, Inc. Key News & Latest Developments
Table 62. Mitsubishi Tanabe Pharma Corporation Company Summary
Table 63. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Offerings
Table 64. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 65. Mitsubishi Tanabe Pharma Corporation Key News & Latest Developments
Table 66. Takeda Pharmaceutical Co., Ltd. Company Summary
Table 67. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Offerings
Table 68. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue (US$, Mn) & (2019-2024)
Table 69. Takeda Pharmaceutical Co., Ltd. Key News & Latest Developments
List of Figures
Figure 1. Cholera Vaccines Segment by Type in 2023
Figure 2. Cholera Vaccines Segment by Application in 2023
Figure 3. Global Cholera Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cholera Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cholera Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cholera Vaccines Revenue in 2023
Figure 8. By Type - Global Cholera Vaccines Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cholera Vaccines Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cholera Vaccines Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cholera Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cholera Vaccines Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cholera Vaccines Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cholera Vaccines Revenue Market Share, 2019-2030
Figure 16. US Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cholera Vaccines Revenue Market Share, 2019-2030
Figure 20. Germany Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 21. France Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cholera Vaccines Revenue Market Share, 2019-2030
Figure 28. China Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. India Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cholera Vaccines Revenue Market Share, 2019-2030
Figure 34. Brazil Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cholera Vaccines Revenue Market Share, 2019-2030
Figure 37. Turkey Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cholera Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. Shantha Biotechnics Private Limited Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. PaxVax, Inc. Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Valneva SE Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Merck and Co., Inc. Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Astellas Pharma, Inc. Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Pfizer, Inc. Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Emergent BioSolutions, Inc. Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
